DOK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Additionally, in vivo experiments revealed that DOK1 and DOK2 double deficiency in mice triggered myeloproliferative disease similar to human chronic myeloid leukemia (CML) (17, 18).